On behalf of a major investment management firm, we conducted a privileged independent investigation into whistleblower allegations of investor harm due to cell formula errors in a valuation model, as well as subsequent allegations of retaliation. Presented findings to the board of directors and the Securities and Exchange Commission. The SEC subsequently determined not to recommend an enforcement action by the Commission against the firm.
A case for AXI
Until recently, banks had routinely tied revolving credit facilities to credit-sensitive benchmarks such as the London Interbank Offered Rate (LIBOR), however...